Ali Mohamed Ashraf, Shaharyar Mohammad, Siddiqui Anees Ahamed
Faculty of Pharmacy, Jamia Hamdard University, Department of Pharmaceutical Chemistry, Hamdard Nagar, New Delhi 110062, India.
Eur J Med Chem. 2007 Feb;42(2):268-75. doi: 10.1016/j.ejmech.2006.08.004. Epub 2006 Sep 26.
In the present investigation, a series of 5-(-4-(substituted) phenyl)-3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-1H-1-pyrazolyl-2-toluidino methane thione and 5-(substituted) phenyl-3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-1H-1-pyrazolyl-2-methoxyanilino methane thione were synthesized by the reaction between hydrazine hydrate and chalcones (3a-k) followed by condensation with appropriate aryl isothiocyanate which yielded N-substituted pyrazoline derivatives. Newly synthesized compounds were tested for their in vitro anti-tubercular activity against Mycobacterium tuberculosis H37Rv using the BACTEC 460 radiometric system. Among the synthesized compounds, compound anilino-3-(4-hydroxy-3-methylphenyl)-5-(2,6-dichlorophenyl)-4,5-dihydro-1H-1-pyrazolylmethanethione (6i) was found to be more active agent against M. tuberculosis H37Rv with minimum inhibitory concentration of 0.0034 microM.
在本研究中,通过水合肼与查耳酮(3a - k)反应,随后与适当的芳基异硫氰酸酯缩合,合成了一系列5 -(- 4 -(取代)苯基)- 3 -(4 - 羟基 - 3 - 甲基苯基)- 4,5 - 二氢 - 1H - 1 - 吡唑基 - 2 - 甲苯胺基甲硫酮和5 -(取代)苯基 - 3 -(4 - 羟基 - 3 - 甲基苯基)- 4,5 - 二氢 - 1H - 1 - 吡唑基 - 2 - 甲氧基苯胺基甲硫酮,得到了N - 取代的吡唑啉衍生物。使用BACTEC 460放射测量系统对新合成的化合物进行了针对结核分枝杆菌H37Rv的体外抗结核活性测试。在合成的化合物中,发现化合物苯胺基 - 3 -(4 - 羟基 - 3 - 甲基苯基)- 5 -(2,6 - 二氯苯基)- 4,5 - 二氢 - 1H - 1 - 吡唑基甲硫酮(6i)是对结核分枝杆菌H37Rv更具活性的药剂,最低抑菌浓度为0.0034 microM。